Mobile Site ›
Normal View

Test ID: FPTHC
PTH Accuratio Comprehensive Profile

Secondary ID A test code used for billing and in test definitions created prior to November 2011

91504

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Method Name A short description of the method used to perform the test

Immunoradiometric assay (IRMA)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

PTH Accuratio Comprehensive Profile

Aliases Lists additional common names for a test, as an aid in searching

PTH Accuratio FORWARD

Specimen Type Describes the specimen type needed for testing

Plasma EDTA

Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.

Draw blood in a lavender-top (EDTA) tube(s). Spin down and

send 2 mL EDTA plasma frozen in a plastic vial.

 

Note: Processing of samples should be completed within one hour

              of blood collection

Reject Due To Identifies specimen types and conditions that may cause the specimen to be rejected

Specimens other than

Plasma

Anticoagulants other than

EDTA

Hemolysis

NA

Thawing

Warm reject; Cold reject

Lipemia

NA

Icteric

NA

Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.

Specimen TypeTemperatureTime
Plasma EDTAFrozen

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

COMPREHENSIVE PROFILE

   

TOTAL PTH Reference Range:     14.0-66.0 pg/mL

CAP PTH Reference Range:             5.0-39.0 pg/mL

CIP VALUE Reference Range:         2.5-29.0 pg/mL

CAP/CIP Reference Range:              1.1-6.9   ratio

 

Low ratio or PTH values are associated with Adynamic bone turnover

status for an ESRD patient.

 

Total PTH:

Total Intact PTH is the sum of CAP PTH and N-truncated PTH

fragment (likely 7-84) Total PTH = Intact PTH = CAP + CIP.

FDA approved.

CAP PTH:

CAP stands for Cyclase Activating PTH and is the same as

Whole PTH which is 1-84 PTH and which raises bone turnover.

FDA approved.

CIP VALUE:

CIP stands for Cyclase Inactive PTH and the N-truncated PTH

fragment, likely 7-84 PTH. CIP = Total PTH – CAP.

CAP/CIP:

CAP/CIP ratio is a calculated value and has been shown to be

93% predictive of bone turnover for the ESRD patient, however,

bone biopsy is 100% predictive, therefore, clinical correlation

is recommended.

  

Reference ranges were established using a 95% reference

interval on a normal population with normal functioning kidneys.

These reference ranges should not be applied to ESRD

patients with impaired or non-functioning renal function.

  

TEST PERFORMED BY:  

SCANTIBODIES CLINICAL LABORATORY, INC.

9236 ABRAHAM WAY

SANTEE, CA  92701

 

Clinical Reference Provides recommendations for further in-depth reading of a clinical nature

REFERENCES:

CAP reference range 90-170 pgm/mL & Ratio <1.4 = Adynamic

Bone Disease

         Tokumoto, A J Amer Soc Nephrol 2003 (Nov); 14:702

         Tokumoto, A J Amer Soc Nephrol 2003 (Nov); 14:700

CAP/CIP Ratio 93% predictive:

          Faugere M-C, Geng Z, Mawad H, Friedler RM, Gao P,

          Cantor T, Malluche H. Kidney Int 2001; 60: 1460-1468.

Total PTH>1000 pg/mL & RATIO <or=1.4=High Bone Turnover

           American Journal of Kidney Diseases, Vol 26, No4 (Oct),

           1995: pp622-31

  

 

TEST PERFORMED BY:  

SCANTIBODIES CLINICAL LABORATORY, INC.

9236 ABRAHAM WAY

SANTEE, CA  92701

 

 

Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.

Varies

Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.

5 days

Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result

7 - 9 days

Performing Laboratory Location The location of the laboratory that performs the test

Scantibodies Clinical Laboratory

CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

83970\x2

LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.

Result IDReporting NameLOINC Code
Z1597Total PTHIn Process
Z1594CAP PTHIn Process
Z1595CIP ValueIn Process
Z1596CAP/CIPIn Process